Quarterly Results

  • Company Name :
Lyka Labs Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500259
  • NSE Symbol:
  • LYKALABS
  • P/E(TTM):
  • 94.97
  • ISIN Demat:
  • INE933A01014
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 1.49
  • Book Value(₹):
  • 36.60
  • Market Cap(₹Cr.):
  • 505.01
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 32.92 41.16 30.10
Excise Duty 0.00 0.00 0.00
Net Sales 32.92 41.16 30.10
Other Operating Income 0.00 0.00 0.00
Other Income 0.87 0.13 0.62
Total Income 33.80 41.28 30.72
Total Expenditure 27.84 35.82 26.05
PBIDT 5.96 5.47 4.67
Interest 0.62 0.52 0.65
PBDT 5.34 4.95 4.02
Depreciation 1.75 1.68 1.68
Tax 0.86 0.84 0.40
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.03 -0.05 0.20
Reported Profit After Tax 2.70 2.47 1.75
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 2.70 2.47 1.75
EPS (Unit Curr.) 0.75 0.69 0.49
EPS (Adj) (Unit Curr.) 0.75 0.69 0.49
Calculated EPS (Unit Curr.) 0.76 0.69 0.49
Calculated EPS (Adj) (Unit Curr.) 0.76 0.69 0.49
Calculated EPS (Ann.) (Unit Curr.) 3.02 2.77 1.96
Calculated EPS (Adj) (Ann.) (Unit Curr.) 3.02 2.77 1.96
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 35.69 35.69 35.69
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 18.10 13.29 15.51
PBDTM(%) 16.22 12.03 13.36
PATM(%) 8.20 6.00 5.81